Vergoeding 2020-2024 voor ATC-subgroep J02AC : Triazool- en tetrazoolderivaten
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| J02AC01 Fluconazol (Diflucan ®) | 720.260 | 668.580 | 768.670 | 786.310 | 1.425.100 |
| J02AC02 Itraconazol (Trisporal ®) | 1.274.100 | 1.176.900 | 1.203.000 | 1.359.700 | 1.406.400 |
| J02AC03 Voriconazol (Vfend ®) | 559.700 | 430.040 | 338.140 | 372.330 | 293.410 |
| J02AC04 Posaconazol (Noxafil ®) | 5.082.600 | 3.304.100 | 3.750.200 | 4.113.200 | 4.291.700 |
| J02AC05 Isavuconazol (Cresemba ®) | 1.024.900 | 842.770 | 1.407.400 | 1.606.400 | 2.097.100 |
| Totaal | 8.661.560 | 6.422.390 | 7.467.410 | 8.237.940 | 9.513.710 |